Evidence map›Paper›PMID 42368241›Full record

ArticleCureus2026

Refractory Hemorrhagic Radiation Proctitis Managed With Sequential Endoscopic, Topical, and Hyperbaric Oxygen Therapy.

Taha Shakarchi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Taha ShakarchiDepartment of Internal Medicine, Beth Israel Lahey Health, Burlington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic radiation proctitis is a recognized late complication of pelvic radiation therapy and may present with rectal bleeding, urgency, altered bowel habits, ulceration, and transfusion-requiring anemia. Management can be challenging when bleeding persists despite standard endoscopic therapy. We present the case of a 72-year-old man with a history of prostate cancer treated with radiation therapy in 2016 who developed refractory hemorrhagic radiation proctitis in 2023. He initially underwent three sessions of argon plasma coagulation (APC) for rectal bleeding but was later hospitalized with acute blood loss anemia requiring transfusion. Colonoscopy demonstrated post-treatment rectal ulcers with visible vessels, which were treated with bipolar electrocautery. He subsequently received compounded sucralfate enemas with improvement in bleeding, followed by repeat endoscopic treatment of residual radiation proctitis with APC. Due to persistent symptoms, mesalamine suppositories and rectal radiofrequency ablation were used. Ongoing bleeding ultimately prompted referral for hyperbaric oxygen therapy, with completion of 30 sessions over seven weeks and resolution of rectal bleeding. Follow-up flexible sigmoidoscopy showed resolution of radiation proctitis with one clean-based rectal ulcer. Biopsies were negative for cytomegalovirus (CMV), herpes simplex virus (HSV), and dysplasia. This case highlights the stepwise and often multimodal management required for refractory chronic radiation proctitis and supports consideration of hyperbaric oxygen therapy when bleeding persists despite topical and endoscopic interventions.

Indexed as

argon plasma coagulationchronic radiation proctitishyperbaric oxygen therapyprostate cancer radiationradiofrequency ablationrectal bleedingsucralfate enema

Identifiers

PMID42368241
PMCPMC13307591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.